Paul Reider

Paul Reider

Former Chief Commercial OfficeratCoherus Oncology· In proxies 2023–2025

Pay in FY2025-26% from the year before · Coherus Oncology stock +2.9% the same year

Paul Reider was paid $1.2M in FY2025 (Dec), down 26%. Coherus Oncology stock rose 2.9% that year.

Pay$100 in the stock at the end of FY22 → $18
Pay is from the Summary Compensation Table of each Coherus Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Coherus OncologyPublic company · 3 yr
    • Former Chief Commercial Officer2023 – Present · 3 yrStock in role -80%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?